Soluble CD163 has previously been associated with HOMA‐IR, a surrogate measure of hepatic IR, in patients with diabetes as well as obese and normal‐weight subjects (Parkner et al., 2012; Zanni et al., 2012). Here, CD163 is linked to diabetes mellitus.